Search results
Matthew Johnson on Family and Medical Leave Act (FMLA) | JD Supra
JD Supra· 49 minutes agoJD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations. This Privacy Policy describes how JD Supra ...
Radioactive drugs strike cancer with precision
Knowable Magazine via Yahoo News· 1 day agoThe drug, marketed as Lutathera, quickly won approval from European and US regulators alike. That’s when Novartis took notice. Although the Swiss drug...
Swiss approve law boosting renewable energy generation
AFP via Yahoo News· 5 days agoSwitzerland approved a law on Sunday aimed at accelerating the development of renewable energies, as...
Aktiia wins CE mark for calibration-free optical blood pressure measuring tech
Medical Device Network via Yahoo Finance· 19 hours agoLiveMetric’s device, called LiveOne, was cleared by the US Food and Drug Administration in 2022 and...
How To Manage A Drug Product In A Medical Device Environment
EnterpriseContentManagementConnection-ECM· 6 days agoA global medical device company approached ProPharma to assess the setup of their entire supply...
Analysis-UBS market strength puts Swiss industry on edge By Reuters
Investing.com· 2 days agoUBS's takeover of Credit Suisse has fed a creeping anxiety that Swiss companies will pay a price for...
The Biden Admin Wants to Remove Medical Debt From Credit Scores
The Central Virginian· 12 hours agoDescription: What’s worse than getting sick? Getting sick AND being stuck with medical debt — here’s...
26 incredible things you probably didn't know about the Himalayas
LoveEXPLORING via Yahoo News· 14 hours agoThen on 1 May 1963, James...Diana Penny-Sherpani created the first Everest Marathon. Despite...
It’s so hot in India, an insurer is helping thousands of women buy food
CNN Business via Yahoo Finance· 2 days agoA one-of-its-kind insurance policy has started making payouts to tens of thousands of women across...
NLS Pharmaceutics Announces Publication of New Patent Application for Next-Gen Dual Non-Sulfonamide...
Digital Journal· 3 days ago(NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company dedicated to pioneering therapies for rare and complex central nervous ...
